Understanding the CMC regulatory landscape for cell and gene therapy products
Understanding the CMC regulatory landscape for cell and gene therapy products
与所有的生物技术产品一样，如果您尚未满足监管机构的检查要求，就可能会造成挽救生命的药物延迟上市。

Added Date:

2022-04-24

Filters:

Filter Category Filter Values
Specialty
  • Other
  • Regulatory
Month
  • September
Year
  • 2021
Capability
  • Viral Vectors
Asset Type
  • Whitepaper
Region
  • Global
Market Category
  • Advanced therapy

Country Availability:


()

Gated Form:

None Set